Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London

• Autori principali: Anjali Rampersad (Autore), Karolina Gholam (Autore), Lea Solman (Autore), Natalia Cartledge (Autore), Sri Gore (Autore), Gabriela Petrof (Autore)
• Natura: Libro
• Pubblicazione: Wiley, 2024-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Dupilumab is the first human monoclonal antibody approved for the treatment of moderate-severe atopic dermatitis (AD) in children from 6 years of age. Real‐world studies reviewing dupilumab‐related ocular surface disorders (DROSD) in the paediatric population are needed to detail...